Skip to content
R

Rola Ali S. Alotabi

Publications (2)

Management of Septic Arthritis in Emergency Department

Mohammed H. Abushal, Yazeed Ali S. Albalawi, Muflih Abdullah S. Albalawi, AlTurki Abdulrahman Mohammed, Amal Sulaiman A. Albalawi, Rola Ali S. Alotabi, Abdulrahim Oudah A. Albalawi, Sultan Suliman Q. Al-Ruwaili, Zahraa Abbas A. Kassarah Al-nakhli, Nada Saleem S. alhawiti, Abdalah Emad Almhmd, Naif Abdullah M. Alzahrani, Turki Abdullah A. Alzahrani, Hassan Ahmed A. Arishi & Musab Ismail Y. Ezzi · Journal of Pharmaceutical Research International · 2021

Bacterial arthritis is an inflammation of the joints caused by an infectious etiology, usually bacterial, but there are also fungi, mycobacteria, viruses, or other rare pathogens. Both healthy and predisposed people can be infected. Nongonococcal infectious arthritis, usually a m...

Open access Research Article 10.9734/jpri/2021/v33i50A33400

Role of Anti-VEGF (Bevacizumab) in Management of Neovascular Glaucoma: A Review

Abdulrahman Arshed N. Alharfy, Marwan Saleh D. Albalawi, Abdulmajeed Mousa Alzahrani, Ruby Naif M. Alsubaie, Amani Ahmad S. Albalawi, Waad Ali Alkaabneh, Abdullah Ibrahim Altidlawi, Amal Nafea J. Alharbi, Afnan Mohammed H. Almutairi & Rola Ali S. Alotabi · Journal of Pharmaceutical Research International · 2021

Neovascular glaucoma (NVG) is an aggressive type of glaucoma, which often results in poor visual outcomes. Antivascular endothelial growth factor is frequently used for various conditions in which VEGF release is induced in response to retinal ischemia. Bevacizumab is a humanized...

Open access Research Article 10.9734/jpri/2021/v33i40A32237